Find Metocurine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Metubine iodide, 7601-55-0, Dimethyl tubocurarine iodide, Metocurine iodide [usan], Dimethylchondrocurarine iodide, O,o'-dimethylchondrocurarine diiodide
Molecular Formula
C40H48I2N2O6
Molecular Weight
906.6  g/mol
InChI Key
DIGFQJFCDPKEPF-OIUSMDOTSA-L
FDA UNII
O0U0E87X7F

Metocurine
Metocurine iodide is a benzylisoquinolinium competitive nondepolarizing neuromuscular blocking agent. It is used as an anesthesia adjunct to induce skeletal muscle relaxation and to reduce the intensity of muscle contractions in convulsive therapy Metocurine iodide has a moderate risk of inducing histamine release and has some ganglion blocking activity. Metocurine iodide can be used most advantageously if muscle twitch response to peripheral nerve stimulation is monitored to assess degree of muscle relaxation. Metocurine Iodide is no longer available on the US market.
1 2D Structure

Metocurine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1S,16R)-9,10,21,25-tetramethoxy-15,15,30,30-tetramethyl-7,23-dioxa-15,30-diazoniaheptacyclo[22.6.2.23,6.18,12.118,22.027,31.016,34]hexatriaconta-3(36),4,6(35),8(34),9,11,18(33),19,21,24,26,31-dodecaene;diiodide
2.1.2 InChI
InChI=1S/C40H48N2O6.2HI/c1-41(2)17-15-27-22-34(44-6)36-24-30(27)31(41)19-25-9-12-29(13-10-25)47-40-38-28(23-37(45-7)39(40)46-8)16-18-42(3,4)32(38)20-26-11-14-33(43-5)35(21-26)48-36;;/h9-14,21-24,31-32H,15-20H2,1-8H3;2*1H/q+2;;/p-2/t31-,32+;;/m0../s1
2.1.3 InChI Key
DIGFQJFCDPKEPF-OIUSMDOTSA-L
2.1.4 Canonical SMILES
C[N+]1(CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C.[I-].[I-]
2.1.5 Isomeric SMILES
C[N+]1(CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C6[C@@H](CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C.[I-].[I-]
2.2 Other Identifiers
2.2.1 UNII
O0U0E87X7F
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Dimethyl Dl-curine Dimethochloride

2. Dimethyl-l-curine Dimethochloride

3. Dimethyl-l-curine Dimethoiodide

4. Dimethylchondrocurarine

5. Dimethylcurarine Dimethochloride

6. Dimethylcurine

7. Dmcdm

8. Metocurine

9. Metocurine Dichloride

10. Metocurine Dichloride(1alpha)-isomer

11. Metocurine Dichloride, (1'alpha)-isomer

12. Metocurine Dichloride, (1beta)-(+-)-isomer

13. Metocurine Dihydroxide

14. Metocurine Diiodide

15. Metocurine Diiodide, (1beta)-(+-)-isomer

16. Metocurine Diiodide, (1beta)-isomer

17. Metocurine, (1'alpha)-isomer

18. Metocurine, (1beta)-isomer

19. Metubine

2.3.2 Depositor-Supplied Synonyms

1. Metubine Iodide

2. 7601-55-0

3. Dimethyl Tubocurarine Iodide

4. Metocurine Iodide [usan]

5. Dimethylchondrocurarine Iodide

6. O,o'-dimethylchondrocurarine Diiodide

7. Dimethyltubocurarinium Iodide

8. Tubocuraranium, 6,6',7',12'-tetramethoxy-2,2,2',2'-tetramethyl-, Diiodide

9. Tetrandrini Dimethiodidum

10. (+)-o,o'-dimethylchondrocurarine Diiodide

11. Metocurine Iodide (usan)

12. O0u0e87x7f

13. Metubine

14. Methyl-curarin

15. Dsstox_cid_2944

16. Dimethylether Of D-tubocurarine Iodide

17. Methyl-curarin [german]

18. Dsstox_rid_76799

19. Dsstox_gsid_22944

20. (1s,16r)-9,10,21,25-tetramethoxy-15,15,30,30-tetramethyl-7,23-dioxa-15,30-diazoniaheptacyclo[22.6.2.23,6.18,12.118,22.027,31.016,34]hexatriaconta-3(36),4,6(35),8(34),9,11,18(33),19,21,24,26,31-dodecaene;diiodide

21. Cas-7601-55-0

22. Tubocurarine, O,o'-dimethyl-, Diiodide

23. Metubine Iodide (tn)

24. Nsc-36388

25. Einecs 231-510-3

26. Nsc 36388

27. Unii-o0u0e87x7f

28. Metocurine Iodide [usan:usp]

29. 6,6',7',12'-tetramethoxy-2,2,2',2'-tetramethyltubocuraranium Diiodide

30. Ncgc00181151-01

31. Chembl1739

32. 13h-4,6:21,24-dietheno-8,12-metheno-1h-pyrido(3',2':14,15)(1,11)dioxacycloeicosino(2,3,4-ij)isoquinolinium, 2,3,13a,14,15,16,25,25a-octahydro-9,18,19,29-tetramethoxy-1,1,14,14-tetramethyl-, Diiodide, (13ar-(13ar*,25as*))-

33. Schembl415745

34. Metocurine Iodide [mi]

35. Chebi:6901

36. Dtxsid9022944

37. Metocurine Iodide [vandf]

38. Metocurine Iodide [mart.]

39. Tox21_112755

40. Tox21_112755_1

41. Db00416

42. Metocurine Iodide [orange Book]

43. 2,2,2',2'-tetramethyl-6,6',7',12'-tetrakis(methyloxy)tubocuraran-2,2'-diium Diiodide

44. Ncgc00263444-01

45. 13h-4,6:21,24-dietheno-8,12-metheno-1h-pyrido(3',2':14,15)(1,11)dioxacycloeicosino(2,3,4-ij)isoquinolinium, 2,3,13a,14,15,16,25,25a-octahydro-9,18,19,29-tetramethoxy-1,1,14,14-tetramethyl-, Diiodide, (13ar,25as)-

46. Dimethyltubocurarinium Iodide [who-dd]

47. D00761

48. Q20817012

49. Tubocuraranium,6,6',7',12'-tetramethoxy-2,2,2',2'-tetramethyl-,diiodide

50. 13h-4,6:21,24-dietheno-8,12-metheno-1h-pyrido(3',2':14,15)(1,11)dioxacycloeicosino(2,3,4-ij)isoquinolinium, 2,3,13a,14,15,16,25,25a-octahydro-9,18,19,29-tetramethoxy-1,1,14,14-tetramethyl-, Iodide (1:2), (13ar,25as)-

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 906.6 g/mol
Molecular Formula C40H48I2N2O6
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Exact Mass906.16018 g/mol
Monoisotopic Mass906.16018 g/mol
Topological Polar Surface Area55.4 Ų
Heavy Atom Count50
Formal Charge0
Complexity1060
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Drug Indication

For use as an anesthesia adjunct to induce skeletal muscle relaxation and to reduce the intensity of muscle contractions in convulsive therapy.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Metocurine iodide is a benzylisoquinolinium competitive nondepolarizing neuromuscular blocking agent. Metocurine iodide has a moderate risk of inducing histamine release and has some ganglion blocking activity. Metocurine iodide can be used most advantageously if muscle twitch response to peripheral nerve stimulation is monitored to assess degree of muscle relaxation. As with other nondepolarizing neuromuscular blockers, the time to onset of paralysis decreases and the duration of maximum effect increases with increasing doses of metocurine iodide. Repeated administration of maintenance doses of metocurine iodide has no cumulative effect on the duration of neuromuscular block if recovery is allowed to begin prior to repeat dosing. Moreover, the time needed to recover from repeat doses does not change with additional doses. Repeat doses can therefore be administered at relatively regular intervals with predictable results.


5.2 MeSH Pharmacological Classification

Neuromuscular Nondepolarizing Agents

Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)


5.3 Biological Half-Life

3 to 4 hours


5.4 Mechanism of Action

Metocurine iodide antagonizes the neurotransmitter action of acetylcholine by binding competitively with cholinergic receptor sites on the motor end-plate. This antagonism is inhibited, and neuromuscular block reversed, by acetylcholinesterase inhibitors such as neostigmine, edrophonium, and pyridostigmine.


Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty